Charlottesville biotech reaches option-to-license agreement on contraceptive gel for men
Charlottesville biotech Contraline Inc. has reached an option-to-license agreement with the Population Council for a contraceptive gel for men. Contraline is currently taking the gel — called Nestorone/Testosterone Transdermal Gel, or NES/T — …